Price (delayed)
$4.07
Market cap
$1.68B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.63
Enterprise value
$1.52B
agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians ...
Highlights
The company's revenue rose by 40% YoY and by 8% QoQ
The EPS is up by 32% since the previous quarter
The gross margin has surged by 111% since the previous quarter but it has dropped by 94% year-on-year
The company's gross profit has surged by 109% QoQ but it has shrunk by 93% YoY
The equity has decreased by 29% YoY and by 18% QoQ
The quick ratio has declined by 16% year-on-year
Key stats
What are the main financial stats of AGL
MarketValuationsEarnings
Shares outstanding
412.3M
Market cap
$1.68B
Enterprise value
$1.52B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.56
Price to sales (P/S)
0.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.25
Revenue
$6.06B
Gross profit
$4.84M
Operating income
-$292.13M
Net income
-$260.15M
EBIT
-$252.52M
EBITDA
-$228.06M
Free cash flow
-$71.03M
Per shareBalance sheetLiquidity
EPS
-$0.63
EPS diluted
-$0.63
Free cash flow per share
-$0.17
Book value per share
$1.14
Revenue per share
$14.75
TBVPS
$3.98
Total assets
$1.73B
Total liabilities
$1.26B
Debt
$34.9M
Equity
$470.95M
Working capital
$305.77M
Debt to equity
0.07
Current ratio
1.27
Quick ratio
1.23
Net debt/EBITDA
0.7
MarginsEfficiencyDividend
EBITDA margin
-3.8%
Gross margin
0.1%
Net margin
-4.3%
Operating margin
-4.8%
Return on assets
-12.5%
Return on equity
-43.1%
Return on invested capital
-50.5%
Return on capital employed
-43.4%
Return on sales
-4.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AGL stock price
How has the agilon health stock price performed over time
Intraday
-0.25%
1 week
-9.96%
1 month
30.45%
1 year
-19.88%
YTD
114.21%
QTD
-6%
Financial performance
How have agilon health's revenue and profit performed over time
Revenue
$6.06B
Gross profit
$4.84M
Operating income
-$292.13M
Net income
-$260.15M
Gross margin
0.1%
Net margin
-4.3%
AGL financials
The gross margin has surged by 111% since the previous quarter but it has dropped by 94% year-on-year
The company's gross profit has surged by 109% QoQ but it has shrunk by 93% YoY
The company's revenue rose by 40% YoY and by 8% QoQ
The net margin has grown by 38% from the previous quarter and by 30% YoY
Growth
What is agilon health's growth rate over time
AGL growth chart
Valuation
What is agilon health stock price valuation
P/E
N/A
P/B
3.56
P/S
0.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.25
Price to earnings (P/E)
The EPS is up by 32% since the previous quarter
Price to book (P/B)
The equity has decreased by 29% YoY and by 18% QoQ
The stock's P/B is 19% more than its last 4 quarters average of 3.0
Price to sales (P/S)
The company's revenue rose by 40% YoY and by 8% QoQ
AGL's P/S is 30% below its last 4 quarters average of 0.4
Efficiency
How efficient is agilon health business performance
The ROE fell by 44% YoY but it rose by 27% QoQ
The return on sales is up by 38% since the previous quarter and by 29% year-on-year
The ROA is up by 32% since the previous quarter
AGL's return on invested capital is down by 30% year-on-year but it is up by 24% since the previous quarter
Dividends
What is AGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AGL.
Financial health
How did agilon health financials performed over time
Assets vs liabilities
agilon health's total assets is 37% more than its total liabilities
agilon health's total assets has decreased by 17% from the previous quarter
agilon health's total liabilities has increased by 17% YoY but it has decreased by 17% QoQ
Debt vs equity
The debt is 93% less than the equity
The company's debt to equity rose by 40% YoY and by 17% QoQ
The equity has decreased by 29% YoY and by 18% QoQ
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.